MARKET

GMED

GMED

Globus Medical
NYSE

Real-time Quotes | Nasdaq Last Sale

64.93
-0.88
-1.34%
Opening 13:40 01/22 EST
OPEN
65.55
PREV CLOSE
65.81
HIGH
65.67
LOW
64.80
VOLUME
82.72K
TURNOVER
--
52 WEEK HIGH
68.20
52 WEEK LOW
33.41
MARKET CAP
6.41B
P/E (TTM)
70.36
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
Medical Implants Market Countries Data, CAGR Status 2020-2025 | Forecasting Analysis by Product Type, by Main Application, by top Regions
Japan, Japan, Fri, 22 Jan 2021 04:38:32 / Comserve Inc. / -- The report offers overview of leading companies encompassing their successful marketing...
Comserve · 9h ago
Artificial Disc Replacement Systems Market 2021 Covid 19 Analysis with Top Countries Data to Showing Impressive Growth by Industry Trends, Share, Size, Top Key Players Analysis and Forecast Research
Jan 22, 2021 (The Expresswire) -- Global“Artificial Disc Replacement SystemsMarket” Report 2021 - 2024 delivers the latest industry data and industry future...
The Express Wire · 13h ago
Orthopedics & Trauma Implants Market 2021 : Top Countries Data with Drivers and Restraints, Business Opportunities, Advancement Technologies and Forecast to 2026
Jan 21, 2021 (The Expresswire) -- Global “Orthopedics and Trauma Implants Market" 2021-2026 Research Report provides key analysis on the market status of the...
The Express Wire · 15h ago
Ortho Biological Products Market Research Methodology Is Expected To Witness Highest Growth In North America And Europe (2022-2031)
marketresearch.biz · 1d ago
Spinal Implants and Surgical Devices Market Development Status, Emerging Technologies, Regional Trends and Comprehensive Research Study 2025
Comserve · 1d ago
Global Spinal Devices Market 2020 Regional Landscape, Market Dynamics, Manufacture Analysis, Industry Demand and Forecast to 2025
Jan 20, 2021 (CDN Newswire via Comtex) -- Global Spinal Devices Market 2020 by Manufacturers, Type and Application, Forecast to 2025 interprets market...
CDN Newswire · 1d ago
Orthopedic Biomaterials Market Outlook | Development Factors, Latest Opportunities and Forecast 2025
Jan 20, 2021 (Market Insight Reports) -- Selbyville, Delaware Market Study Report, LLC, has added a detailed study on the Orthopedic Biomaterials market...
Market Insight Reports · 1d ago
Global Disc Prostheses Market 2020 Comprehensive Research Methodology, Key Insights, Segments and Extensive Profiles by 2025
Jan 20, 2021 (CDN Newswire via Comtex) -- Global Disc Prostheses Market 2020 by Manufacturers, Type and Application, Forecast to 2025 is the latest market...
CDN Newswire · 1d ago
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of GMED. Analyze the recent business situations of Globus Medical through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 16 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average GMED stock price target is 67.07 with a high estimate of 79.00 and a low estimate of 55.00.
EPS
Institutional Holdings
Institutions: 404
Institutional Holdings: 66.09M
% Owned: 66.98%
Shares Outstanding: 98.68M
TypeInstitutionsShares
Increased
94
3.04M
New
98
861.64K
Decreased
133
6.10M
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
+0.07%
Healthcare Equipment & Supplies
-0.03%
Key Executives
Chairman/Executive Director
David Paul
President/Chief Executive Officer/Director
David Demski
Chief Financial Officer/Senior Vice President
Keith Pfeil
Executive Vice President/IR Contact Officer
Daniel Scavilla
Senior Vice President/General Counsel/Secretary
Kelly Huller
Independent Director
David Davidar
Independent Director
Robert Douglas
Independent Director
Daniel Lemaitre
Independent Director
Ann Rhoads
Independent Director
James Tobin
Independent Director
Steve Zarrilli
  • Dividends
  • Splits
  • Insider Activity
No Data
Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
About GMED
Globus Medical, Inc. is a medical device company. The Company is focused on developing products for patients with musculoskeletal disorders. It is focused on products to treat patients with spine disorders. The Company's products fall under categories, which include Innovative Fusion and Disruptive Technologies. The Innovative Fusion category products include fusion products to treat spinal disorders for the entire spine, and they can be used in various surgical approaches. The Disruptive Technologies category represents a shift in the treatment of spinal disorders by allowing for surgical procedures and the treatment of spinal disorders. QUARTEX is its Occipito-Cervico-Thoracic (OCT) stabilization system. QUARTEX features a threading locking cap to enable low-torque. The Company's portfolio of approved and pipeline Disruptive Technology products includes products that allow for minimally invasive surgical (MIS) techniques.
More

Webull offers kinds of Globus Medical Inc stock information, including NYSE:GMED real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GMED stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading GMED stock methods without spending real money on the virtual paper trading platform.